Crinetics Pharmaceuticals Overview

  • Founded
  • 2008
Founded
  • Status
  • Public
  • Employees
  • 68
Employees
  • Stock Symbol
  • CRNX
Stock Symbol
  • Share Price
  • $13.94
  • (As of Friday Closing)

Crinetics Pharmaceuticals General Information

Description

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 10222 Barnes Canyon Road
  • Building No. 2
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Crinetics Pharmaceuticals Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Crinetics Pharmaceuticals Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$13.94 $14.60 $10.63 - $26.67 $458M 32.9M 100K -$2.41

Crinetics Pharmaceuticals Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 467,300 481,804 551,215
Revenue 897 1,193 2,428 2,045
EBITDA (64,200) (52,995) (28,392) (9,055)
Net Income (62,830) (50,422) (27,115) (9,157)
Total Assets 217,122 130,377 171,415 15,598
Total Debt 4,444 4,849 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Crinetics Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Crinetics Pharmaceuticals‘s full profile, request access.

Request a free trial

Crinetics Pharmaceuticals Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Crinetics Pharmaceuticals‘s full profile, request access.

Request a free trial

Crinetics Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and comm
Biotechnology
San Diego, CA
68 As of 2019
00000
000000 - 000 00000

00000000

enderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupi
0000 000000000
San Carlos, CA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000 000000000
Paris, France
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Crinetics Pharmaceuticals Competitors (22)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apexigen Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
00000 Formerly VC-backed Paris, France 00 00000 000000000 00000
0000000 0000000000 Formerly VC-backed San Diego, CA 000 00000 00000000 00000
00000000000 000000 Formerly VC-backed Newark, CA 00 00000 000000 - 000 00000
00000000 000000000 Formerly VC-backed Newtown, PA 00 00000 00000000 00000
You’re viewing 5 of 22 competitors. Get the full list »

Crinetics Pharmaceuticals Executive Team (8)

Name Title Board Seat Contact Info
Ajay Madan Ph.D Executive
Richard Struthers Ph.D Co-Founder, Chief Executive Officer & Board Member
Marc Wilson Chief Financial Officer, Finance & Chief Accounting Officer, Accounting
Adriana Cabré Vice President of Human Resources
Alan Krasner MD Chief Medical Officer
You’re viewing 5 of 8 executive team members. Get the full list »

Crinetics Pharmaceuticals Board Members (12)

Name Representing Role Since
Camille Bedrosian MD Self Board Member 000 0000
David Allison Ph.D 5AM Ventures Board Observer 000 0000
Matthew Fust Self Board Member 000 0000
Richard Struthers Ph.D Crinetics Pharmaceuticals Co-Founder, Chief Executive Officer & Board Member 000 0000
Stephanie Okey Self Board Member 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Crinetics Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Crinetics Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Crinetics Pharmaceuticals‘s full profile, request access.

Request a free trial